Related Experiment Video
Updated: Jan 6, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Th9/IL-9 axis mediates airway fibrosis in traumatic tracheal stenosis via TGF-β1/SMAD2/3 signaling
Tingmei Feng1, Yu Li1, Jinmei Wei1
1Department of Respiratory Medicine, The Second Affiliated Hospital of Guangxi Medical University, No. 166 Daxuedong Road, Xixiangtang District, Nanning City, Guangxi, 530007, P.R. China.
Abstract:
Although Th9 cells and their hallmark cytokine IL-9 are implicated in fibrotic diseases, their role in traumatic tracheal stenosis (TS) remains unclear. To clarify their role, we examined Th9 and IL-9 in human and rat models both in vitro and in vivo. First, we observed significantly elevated PU.1, IRF4, and IL-9 expression in patients with TS (n = 10), suggesting enhanced Th9-related immune responses. To assess the functional relevance of this finding, we then employed a rat TS model induced by nylon brush injury and a CD4+ T cell-fibroblast co-culture system. We found that IL-9 activated fibroblasts and robustly promoted collagen synthesis via the TGF-β1/SMAD2/3 pathway. Notably, neutralization of IL-9 or inhibition of TGF-β1 signaling markedly reduced collagen deposition and restored Th1/Th2 cytokine balance in both in vitro (n = 5) and in vivo (n = 6) models. Proteomic analysis further confirmed IL-9-driven activation of immune-fibrotic networks. These findings establish the Th9/IL-9 axis as a key mediator of airway fibrosis in TS and support its potential as a novel immunotherapeutic target.
Related Concept Videos
TGF - β Signaling Pathway
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...

